comprehensive -WSS

comprehensive

author：fashion 2025-09-30 12:57:27 - browse：61

What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them. We also discuss the approval of Eli Lilly’s curiously named treatment for obesity, the latest implosion for a promising biotech company, and some news in the world of shareholder activism.

For more on what we cover, here’s the radiopharmaceuticals story; here’s the news on Lilly; here’s more on Ventyx Biosciences; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： What does generative AI mean for health care? We asked experts
Next article： GSK Flovent asthma inhalers replaced by authorized generics

WSS

Roche to buy Carmot Therapeutics, developer of obesity drugs

Federal weight loss drug coverage is 30 years out of date

Patients' immediate access to test results puts radiologists in a bind

Federal weight loss drug coverage is 30 years out of date

3 trends to watch in health tech's hiring outlook for 2024

In diabetes hearing, Sanders takes on a new foe: food makers

hotspot

comprehensive

explore

George Santos makes 1st court appearance after pleading not guilty to 13 counts

STAT letters to the editor on burnt

New air purifier tech could be key to improving indoor air quality

Feng Zhang, Grail founder join forces on new gene editing startup

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Why sickle cell disease is getting the first CRISPR treatment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Chronically ill young patients struggle to find fertility info

What does generative AI mean for health care? We asked experts

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

focus

GSK Flovent asthma inhalers replaced by authorized generics

What PEPFAR has meant on the ground in Ukraine

FDA approves world's first CRISPR

What PEPFAR has meant on the ground in Ukraine

The FDA must approve intranasal treatments for anaphylaxis

AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B

hotspot

focus

leisure time

leisure time